Bhamini is a Venture Associate with Mass General Brigham Ventures, focusing on early-stage company creation. She is an experienced scientist with more than 10 years of experience in the biotech/pharma industry and has helped to guide multiple early-stage drug discovery programs. Bhamini previously led several oncology programs at Servier Pharmaceuticals, and at Agios Pharmaceuticals, where she focused on Oncology and Rare Genetic Diseases both as a Scientist and within Business Development. Preceding that she was at Boehringer Ingelheim, and Memorial Sloan Kettering Cancer Center (MSKCC) leading Structure Based Drug Discovery programs. Bhamini holds a B.A. in Natural Sciences (Tripos) from University of Cambridge, a B.Sc. in Biochemistry from University of Delhi, an M.Sc. in Biophysics from NYU, and an M.B.A. in Finance from the Carroll School of Management at Boston College.